Ling Xie Selected Research

Ling Xie Research Topics

Disease

27	Neoplasms (Cancer) 01/2022 - 01/2003
10	Inflammation (Inflammations) 01/2022 - 03/2013
8	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2018
8	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2013
6	Carcinogenesis 01/2022 - 02/2002
5	Lung Neoplasms (Lung Cancer) 01/2020 - 02/2002
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2022 - 01/2018
4	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2003
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2019
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 09/2017
3	Critical Illness (Critically Ill) 08/2022 - 08/2017
3	Triple Negative Breast Neoplasms 07/2022 - 11/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2018
3	COVID-19 08/2021 - 08/2020
3	Hypoxia (Hypoxemia) 01/2020 - 04/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2002
3	Carcinoma (Carcinomatosis) 08/2012 - 07/2011
2	Heart Failure 01/2022 - 01/2018
2	Fibrosis (Cirrhosis) 01/2022 - 12/2018
2	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2021
2	Acute Coronary Syndrome 02/2021 - 01/2021
2	Atherosclerosis 01/2021 - 01/2018
2	Pain (Aches) 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 10/2012
2	Albuminuria 01/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 01/2018
2	Pancreatitis 01/2019 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2018 - 11/2015
2	Infections 08/2017 - 08/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2015 - 10/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 11/2005
2	Esophageal Squamous Cell Carcinoma 08/2012 - 07/2011
1	Stroke (Strokes) 08/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 05/2022
1	Neuralgia (Stump Neuralgia) 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Atrial Fibrillation 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Multiple Sclerosis 12/2021
1	Immune System Diseases (Immune Disorders) 10/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
6	Messenger RNA (mRNA)IBA 01/2021 - 02/2002
6	Peptides (Polypeptides)IBA 01/2019 - 05/2002
5	CytokinesIBA 01/2020 - 01/2018
5	ProteomeIBA 01/2017 - 01/2003
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 10/2012
4	isoliquiritigenin (GU 17)IBA 01/2019 - 01/2018
3	CateninsIBA 01/2022 - 10/2018
3	MicroRNAs (MicroRNA)IBA 10/2021 - 05/2014
3	Biological ProductsIBA 01/2021 - 07/2011
3	EndotoxinsIBA 11/2020 - 03/2013
3	Pharmaceutical PreparationsIBA 08/2020 - 01/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2005
3	IronIBA 12/2018 - 08/2012
2	Proteolysis Targeting ChimeraIBA 07/2022 - 01/2020
2	SolutionsIBA 05/2022 - 01/2020
2	artemisinin (artemisinine)IBA 01/2022 - 10/2021
2	Carrier Proteins (Binding Protein)IBA 11/2021 - 06/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021 - 11/2012
2	LipidsIBA 01/2021 - 01/2018
2	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021 - 12/2018
2	Freund's AdjuvantIBA 01/2021 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 11/2015
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 01/2018
2	Nerve Growth Factor (NGF)IBA 01/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2011
2	oxalylglycineIBA 01/2020 - 12/2019
2	Neuroprotective AgentsIBA 01/2020 - 05/2012
2	EnzymesIBA 11/2019 - 05/2019
2	ChromatinIBA 07/2019 - 03/2013
2	Therapeutic UsesIBA 10/2017 - 11/2015
2	Phenobarbital (Luminal)FDA Link 03/2016 - 02/2016
2	Methylphenidate (Ritalin)FDA LinkGeneric 10/2015 - 10/2011
2	SERPIN-B5 (maspin)IBA 05/2003 - 01/2003
1	Enhancer of Zeste Homolog 2 ProteinIBA 07/2022
1	Polycomb Repressive Complex 2IBA 07/2022
1	methyl butyrateIBA 06/2022
1	Purinergic P2X3 ReceptorsIBA 05/2022
1	Scopolamine (Hyoscine)FDA Link 05/2022
1	Protein Kinase CIBA 05/2022
1	sesamolIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	LigandsIBA 01/2022
1	Laminin (Merosin)IBA 01/2022
1	OligonucleotidesIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	TPN10466IBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Aurora Kinase BIBA 12/2021
1	methyl acetateIBA 12/2021
1	SolventsIBA 12/2021
1	Acetates (Acetic Acid Esters)FDA Link 12/2021
1	CalciumIBA 11/2021
1	IntegrinsIBA 11/2021

Therapy/Procedure

14	Therapeutics 12/2021 - 11/2005
4	Drug Therapy (Chemotherapy) 01/2018 - 03/2003
1	Subcutaneous Injections 05/2022
1	Electroacupuncture 05/2022